Rhodococcus equi is a gram-positive, facultative intracellular respiratory pathogen which causes severe pneumonia in young horses and immunodeficient humans (3, 12) . Pulmonary disease is characterized by chronic pyogranulomatous inflammation and progressive loss of respiratory function due to the inability of alveolar macrophages to kill phagocytized R. equi (23, 24) . In immunodeficient animals and humans, antibiotics can reduce bacterial numbers but not effect clearance of the organism (1, 4, 6, 9, 11, 14, 15, 18) . Specifically, human immunodeficiency virus-infected patients with opportunistic R. equi infections frequently have relapses requiring lifelong antibiotic therapy (1, 4, 6, 14, 18) . Identification of the immune mechanisms that mediate clearance of R equi from the lungs would provide a basis for appropriate adjunct immunotherapy.
Immunodeficient mice are susceptible to R equi and provide a model to test the role of T-lymphocyte subsets in pulmonary immunity against R equi (2, 8, 10, 20) . Previous studies have shown that severe combined immunodeficient (SCID) mice which lack T and B lymphocytes and athymic nude mice which lack T lymphocytes are unable to clear pulmonary R. equi infection (9, 20) . In contrast, immunocompetent mice clear the infection by 21 days (8, 10, 20) . These findings, in combination with the failure of human immunodeficiency virus-positive humans with low numbers of CD4+ T cells to control R. equi infection, support the hypothesis that T lymphocytes function in the clearance of pulmonary R equi. We investigated, in two independent experiments, the role of CD4+ T lymphocytes and CD8+ T lymphocytes in bacterial clearance from murine lungs. R equi ATCC 33701 is a virulent strain that possesses the 82-kb plasmid and expresses the 15-to 17-kDa proteins associated with R equi virulence (16, 17) . Avirulent strain 6939 lacks the plasmid and does not express the 15-to 17-kDa proteins (16, 17) . Each strain was characterized, prior to inoculation, for the presence or lack of the virulenceassociated plasmid by agarose gel electrophoresis as previously described (data not shown) (17) . In addition, presence or absence of the virulence-associated proteins was confirmed by immunoblotting (Fig. 1) . Briefly, bacterial proteins were electrophoretically separated, transferred to nitrocellulose, and reacted with a 1:1,000 dilution of either normal horse serum or serum from an R equi-infected foal. Antibody binding was detected with horseradish peroxidase-* Corresponding author. labeled goat anti-equine immunoglobulin G antibody and enhanced chemiluminescence.
The role of CD8+ T lymphocytes in the clearance of pulmonary R equi was investigated with transgenic mice deficient in CD8+ T lymphocytes (GenPharm International, Mountain View, Calif.) and C.B-17 Icr Tac DF SCID mice (Taconic, Germantown, N.Y.). CD8+ T-lymphocyte-deficient mice (32m-/-) were produced by inactivation of the 12 microglobulin gene, leading to failure to express major histocompatibility complex class I surface antigens and severe deficiency of functional CD8+ T lymphocytes (21, 22) . These mice will be referred to as 132m-/-CD8+ T-lymphocyte-deficient mice. Mice heterozygous for the 132 microglobulin gene disruption (02m+/-) express major histocompatibility complex class I antigens, have functional CD8+ T lymphocytes, and were used as immunocompetent controls for the 02m-/-CD8+ T-lymphocyte-deficient mice. Immunocompetent BALB/c mice served as controls for SCID mice. Prior to each experiment, the specific T-lymphocyte subset deficiency was confirmed, in three mice per group, by flow cytometric analysis of peripheral blood mononuclear cells or splenocytes. Surface-bound monoclonal antibodies 2.43, GK1.5, and B220, which recognize CD8+ T lymphocytes, CD4+ T lymphocytes, and B lymphocytes, respectively, were detected with fluorescein isothiocyanate-labeled mouse anti-rat immunoglobulin G (Table 1) . Twenty mice of each strain were anesthetized with intraperitoneal ketamine and xylazine and inoculated intratracheally with 2 x 107 either virulent or avirulent R equi bacteria. Five mice from each group were euthanized at 3 and 21 days postchallenge. Lungs were collected and weighed aseptically, minced in 1.0 ml of sterile phosphatebuffered saline, and homogenized in a laboratory stomacher for 45 s. Tissue homogenates were serially diluted on modified selective media and incubated for 48 h at 37°C to determine the number of CFU (19) . Lung weights were not significantly different between mouse strains (data not shown). The means and standard deviations for CFUs were determined for each group. A Kruskal-Wallis nonparametric one-way analysis of variance and least significant difference were used to determine significant differences. The virulence-associated phenotype of bacteria isolated from the lungs of infected mice was compared to that of the inoculated bacteria by immunoblotting. In all mice, the phenotype of the isolated bacteria was identical to that of the inoculated bacteria. Immunoblots of representative isolates from SCID mice are shown in Fig. 1 . At day 3, the P2m-/-CD8+ T-lymphocyte-deficient mice resembled SCID mice in their decreased ability to contain acute pulmonary infection with virulent strain 33701 ( Fig.  2A) . In contrast, significantly (P < 0.05) fewer bacteria were recovered from the lungs of both immunocompetent BALB/c mice and P2m+/-controls ( Fig. 2A) . At 21 days postinfection, SCID mice were still unable to clear the virulent R equi strain from the lungs. However, P2m-/-CD8+ T-lymphocyte-deficient mice were identical to immunocompetent mice in the ability to clear virulent R. equi infection ( Fig. 2A ). There were no significant differences among mouse strains in the ability to control avirulent strain 6939 at 3 days postinfection (Fig. 2B) . In contrast, all mice were able to clear avirulent bacteria by 21 days, including SCID and 02m-I-CD8+ T-lymphocyte-deficient mice (Fig.   2B ).
To investigate the role of CD4+ T lymphocytes in the clearance of pulmonary R. equi, we used transgenic mice deficient in CD4+ T lymphocytes (Genpharm) and C.B-17 Icr Tac DF SCID mice. CD4+ T-lymphocyte-deficient mice were generated by disruption of the major histocompatibility complex Ab, gene (5) . These mice do not express major histocompatibility complex class II molecules on cell surfaces and lack functional class II-restricted CD4+ cells. Congenic C57BL/6 mice (Taconic) were used as immunocompetent controls. Fifteen mice of each strain were anesthetized and inoculated intratracheally with 2 x 107 virulent R equi bacteria at 6 weeks of age. Five mice from each group were euthanized at 3, 21, and 28 days postchallenge. Lungs were collected and weighed aseptically, homogenized, and serially diluted on modified selective media to determine the numbers of CFUs as described for the previous experiment. At day 3, CD4+ T-lymphocyte-deficient mice resembled SCID mice and had high numbers of bacteria in their lungs; however, bacterial numbers were not significantly different from those of immunocompetent C57BL/6 mice (Fig. 3) . In contrast to immunocompetent strains and 12m-I-CD8+ T-lymphocyte-deficient mice, CD4+ T-lymphocyte-deficient mice were unable to clear bacteria completely by 21 days. To determine whether clearance was prevented or merely delayed, mice were also examined at 28 days postinfection. R. equi persistence in CD4+ T-lympho- (7) . Although enhanced -y/8 or CD8+ responses may also help to contain R equi infection in mice, these compensatory mechanisms are not sufficient to mediate clearance in the absence of CD4+ T cells (13) .
The ability of all strains of mice, including SCID mice, to clear the avirulent strain of R equi effectively by 21 days indicates that bacterial virulence factors are involved in the pathogenesis of R. equi pneumonia. These factors are encoded, at least in part, by the 82-kb plasmid, whose presence correlates closely with in vivo virulence for mice (17) . Because 
